Cameron Ashbaugh | UCSF Profiles

Cameron Ashbaugh, MD

Title	Professor
Institution	University of California San Francisco
Department	Medicine
Address	513 Parnassus Avenue San Francisco CA 94117
vCard	Download vCard

Research

Research Activities and Funding

GROUP A STREPTOCOCCAL HYALURONATE LYASE
NIH/NIAID R21AI048743Sep 30, 2001 - Sep 29, 2003
Role: Principal Investigator

ABC TRANSPORTER IN GROUP A STREPTOCOCCUS
NIH/NIAID K11AI001343Sep 30, 1995 - Aug 31, 2000
Role: Principal Investigator

CAPSULE GENE IN GROUP A STREPTOCOCCUS
NIH/NIAID F32AI008773Mar 1, 1993
Role: Principal Investigator

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Silver JN, Ashbaugh CD, Miles JJ, Wu H, Marecki GT, Hwang JK, Jiao JA, Abrams M, Sullivan EJ, Wesemann DR. Deployment of Transchromosomal Bovine for Personalized Antimicrobial Therapy. Clin Infect Dis. 2018 Mar 19; 66(7):1116-1119. PMID: 29272362.

View in: PubMed
Weaver MJ, Ashbaugh C. Invited Commentary. J Orthop Trauma. 2017 11; 31(11):595. PMID: 28827505.

View in: PubMed
Furtek KJ, Kubiak DW, Barra M, Varughese CA, Ashbaugh CD, Koo S. High incidence of neutropenia in patients with prolonged ceftaroline exposure. J Antimicrob Chemother. 2016 07; 71(7):2010-3. PMID: 27076105; PMCID: PMC4896407 [Available on 07/01/17].

View in: PubMed, PubMed Central
Piantadosi A, Rubin DB, McQuillen DP, Hsu L, Lederer PA, Ashbaugh CD, Duffalo C, Duncan R, Thon J, Bhattacharyya S, Basgoz N, Feske SK, Lyons JL. Emerging Cases of Powassan Virus Encephalitis in New England: Clinical Presentation, Imaging, and Review of the Literature. Clin Infect Dis. 2016 Mar 15; 62(6):707-713. PMID: 26668338; PMCID: PMC4850925 [Available on 03/15/17].

View in: PubMed, PubMed Central
Sierig G, Cywes C, Wessels MR, Ashbaugh CD. Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun. 2003 Jan; 71(1):446-55. PMID: 12496195; PMCID: PMC143243.

View in: PubMed, PubMed Central
Bricker AL, Cywes C, Ashbaugh CD, Wessels MR. NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol Microbiol. 2002 Apr; 44(1):257-69. PMID: 11967084.

View in: PubMed